Renal and extrarenal effects of gum arabic (Acacia senegal) - What can be learned from animal experiments?

Kidney and Blood Pressure Research

Volumn 37, Issue 4-5, 2013, Pages 269-279

  Nasir, Omaima ^a  

^a TAIF UNIVERSITY   (Saudi Arabia)

Author keywords

Chronic renal disease; Colon carcinoma; Diabetes; Inflammation; Obesity; Plasma phosphate concentration; Proteinuria

Indexed keywords

ACACIA SENEGAL EXTRACT; AMINO ACID TRANSPORTER; ANGIOGENIN; ANGIOGENIN 1; ANGIOGENIN 3; ANGIOGENIN 4; AQUAPORIN 4; BETA CATENIN; CALCIUM ION; CD38 ANTIGEN; CREATININE; GLUCOSE; INTERLEUKIN 18; MAGNESIUM ION; NATURAL PRODUCT; PHOSPHATE; RANTES; SODIUM; SODIUM GLUCOSE COTRANSPORTER 1; SULFATASE; SULFATASE 1; UBIQUITIN; UBIQUITIN D; UNCLASSIFIED DRUG; UREA; VASOPRESSIN; ESTERASE; GROWTH FACTOR; GUM ARABIC; PROTEIN;

ACACIA SENEGAL; ADAPTIVE IMMUNITY; ANTIGEN PRESENTING CELL; ANTIMALARIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; BLOOD PRESSURE; CALCIUM EXCRETION; CARCINOGENESIS; CELL MATURATION; CHRONIC KIDNEY FAILURE; COLON CARCINOMA; CREATININE CLEARANCE; CYTOKINE RELEASE; DENDRITIC CELL; DIABETES MELLITUS; DIABETIC NEPHROPATHY; EXPERIMENTAL ANIMAL; EXPERIMENTAL MOUSE; GLUCOSE TRANSPORT; GLUCOSURIA; HYPERGLYCEMIA; HYPERINSULINEMIA; INFLAMMATORY DISEASE; INNATE IMMUNITY; INTESTINE ABSORPTION; KIDNEY FAILURE; MAGNESIUM EXCRETION; MALARIA; NATRIURESIS; NEOPLASM; NONHUMAN; OBESITY; ONCOGENE; PHOSPHATE BLOOD LEVEL; PHOSPHATE EXCRETION; PHOSPHATURIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEINURIA; REVIEW; SODIUM EXCRETION; THERAPY EFFECT; UREA BLOOD LEVEL; URINARY EXCRETION; URINE FLOW RATE; VAV3 ONCOGENE; WEIGHT GAIN; COLON TUMOR; RODENT MALARIA;

ANIMALS; BLOOD PRESSURE; DISEASE MODELS, ANIMAL; GUM ARABIC; HUMANS; KIDNEY; MICE; NEOPLASMS;

EID: 84890412897     PISSN: 14204096     EISSN: 14230143     Source Type: Journal    
DOI: 10.1159/000350152     Document Type: Review

References (118)

1. Tiss A, Carriere F, Verger R: Effects of gum arabic on lipase interfacial binding and activity. Anal Biochem 2001;294:36-43
2. Deckwer WD, Dill B, Eisenbrand E, Bornscheuer U, Pühler A, Heiker FR, Kirschning A, Schreier P, Fugmann B, Pohnert G, Gamse T, Hulpke H: Römpp Online. Georg-Thieme-Verlag 2006;Stuttgart
3. Younes H, Garleb K, Behr S, Remesy C, Demigne C: Fermentable fibers or oligosaccharides reduce urinary nitrogen excretion by increasing urea disposal in the rat cecum. J Nutr 1995;125:1010-1016
4. Phillips GO: Acacia gum (Gum Arabic): A nutritional fibre; metabolism and calorific value. Food Addit Contam 1998;15:251-264
5. Anderson DM: Evidence for the safety of gum arabic (Acacia senegal (L.) Willd.) as a food additive-A brief review. Food Addit Contam 1986;3:225-230
6. Al Majed AA, Mostafa AM, Al Rikabi AC, Al Shabanah OA: Protective effects of oral arabic gum administration on gentamicin-induced nephrotoxicity in rats. Pharmacol Res 2002;46:445-451
7. Ali BH, Ziada A, Blunden G: Biological effects of gum arabic: A review of some recent research. Food Chem Toxicol 2009;47:1-8
8. Al Mosawi AJ: The challenge of chronic renal failure in the developing world: Possible use of acacia gum. Pediatr Nephrol 2002;17:390-391
9. Nasir O, Artunc F, Saeed A, Kambal MA, Kalbacher H, Sandulache D, Boini KM, Jahovic N, Lang F: Effects of gum arabic (Acacia senegal) on water and electrolyte balance in healthy mice. J Ren Nutr 2008;18:230-238
10. Friedman PA: Mechanisms of renal calcium transport. Exp Nephrol 2000;8:343-350
11. Hoenderop JG, Nilius B, Bindels RJ: Molecular mechanism of active Ca2+ reabsorption in the distal nephron. Annu Rev Physiol 2002;64:529-549
12. Murer H, Biber J: A molecular view of proximal tubular inorganic phosphate (Pi) reabsorption and of its regulation. Pflugers Arch 1997;433:379-389
13. Matsumoto N, Riley S, Fraser D, Al Assaf S, Ishimura E, Wolever T, Phillips GO, Phillips AO: Butyrate modulates TGF-beta1 generation and function: Potential renal benefit for Acacia(sen) SUPERGUM (gum arabic)? Kidney Int 2006;69:257-265
14. Bliss DZ: Dietary fiber in conservative management of chronic renal failure. Pediatr Nephrol 2004;19:1069- 1070
15. Fioretto P, Trevisan R, Velussi M, Cernigoi A, De Riva C, Bressan M, Doria A, Pauletto N, Angeli P, De Dona C: Glomerular filtration rate is increased in man by the infusion of both D, L-3-hydroxybutyric acid and sodium D, L-3-hydroxybutyrate. J Clin Endocrinol Metab 1987;65:331-338
16. Alter ML, Ott IM, von Websky K, Tsuprykov O, Sharkovska Y, Krause-Relle K, Raila J, Henze A, Klein T, Hocher B: DPP-4 inhibition on top of angiotensin receptor blockade offers a new therapeutic approach for diabetic nephropathy. Kidney Blood Press Res 2012;36:119-130
17. Deshmukh AB, Patel JK, Prajapati AR, Mishra B: Investigating the effect of CoCl2 administration on diabetic nephropathy and associated aortic dysfunction. Kidney Blood Press Res 2012;35:694-697
18. Tanhauserova V, Tomandl J, Pacal L, Kleparnik M, Maluskova D, Bartakova V, Kuricova K, Rehorova J, Stepankova S, Svojanovsky J, Olsovsky J, Belobradkova J, Krusova D, Jurajda M, Muzik J, Pavlik T, Kankova K: ADMA, SDMA and L-Arginine/ADMA ratio but not DDAH genetic polymorphisms are reliable predictors of diabetic nephropathy progression as identified by competing risk analysis. Kidney Blood Press Res 2012;36:200-208
19. Schernthaner G: Kidney disease in diabetology: Lessons from 2007. Nephrol Dial Transplant 2008;23:1112- 1115
20. Nasir O, Umbach AT, Rexhepaj R, Ackermann TF, Bhandaru M, Ebrahim A, Artunc F, Kempe DS, Puchchakayala G, Siraskar B, Foller M, Saeed A, Lang F: Effects of gum arabic (Acacia senegal) on renal function in diabetic mice. Kidney Blood Press Res 2012;35:365-372
21. Hong EG, Jung DY, Ko HJ, Zhang Z, Ma Z, Jun JY, Kim JH, Sumner AD, Vary TC, Gardner TW, Bronson SK, Kim JK: Nonobese, insulin-deficient Ins2Akita mice develop type 2 diabetes phenotypes including insulin resistance and cardiac remodeling. Am J Physiol Endocrinol Metab 2007;293:E1687-E1696
22. Lang F: Osmotic diuresis. Ren Physiol 1987;10:160-173
23. Albaaj F, Hutchison A: Hyperphosphataemia in renal failure: Causes, consequences and current management. Drugs 2003;63:577-596
24. Silver J, Levi R: Cellular and molecular mechanisms of secondary hyperparathyroidism. Clin Nephrol 2005;63:119-126
25. Cozzolino M, Brancaccio D, Gallieni M, Slatopolsky E: Pathogenesis of vascular calcification in chronic kidney disease. Kidney Int 2005;68:429-436
26. Weston AH, Absi M, Ward DT, Ohanian J, Dodd RH, Dauban P, Petrel C, Ruat M, Edwards G: Evidence in favor of a calcium-sensing receptor in arterial endothelial cells: Studies with calindol and Calhex 231. Circ Res 2005;97:391-398
27. Jung J, Foroud TM, Eckert GJ, Flury-Wetherill L, Edenberg HJ, Xuei X, Zaidi SA, Pratt JH: Association of the calcium-sensing receptor gene with blood pressure and urinary calcium in African-Americans. J Clin Endocrinol Metab 2009;94:1042-1048
28. Abbate M, Zoja C, Remuzzi G: How does proteinuria cause progressive renal damage? J Am Soc Nephrol 2006;17:2974-2984
29. Agarwal R: Vitamin D, proteinuria, diabetic nephropathy, and progression of CKD. Clin J Am Soc Nephrol 2009;4:1523-1528
30. Agrawal V, Marinescu V, Agarwal M, McCullough PA: Cardiovascular implications of proteinuria: An indicator of chronic kidney disease. Nat Rev Cardiol 2009;6:301-311
31. Bianchi S, Bigazzi R, Campese VM: Intensive Versus Conventional Therapy to Slow the Progression of Idiopathic Glomerular Diseases. Am J Kidney Dis 2010;55:671-681
32. Kalaitzidis RG, Bakris GL: Should proteinuria reduction be the criterion for antihypertensive drug selection for patients with kidney disease? Curr Opin Nephrol Hypertens 2009;18:386-391
33. Levey AS, Cattran D, Friedman A, Miller WG, Sedor J, Tuttle K, Kasiske B, Hostetter T: Proteinuria as a surrogate outcome in CKD: Report of a scientific workshop sponsored by the National Kidney Foundation and the US Food and Drug Administration. Am J Kidney Dis 2009;54:205-226
34. Staples A, Wong C: Risk factors for progression of chronic kidney disease. Curr Opin Pediatr 2010;22:161-169
35. Basturk T, Unsal A: Is insulin resistance a risk factor for the progression of chronic kidney disease? Kidney Blood Press Res 2011;34:111-115
36. Paterno JC, Bergamaschi CT, Campos RR, Higa EM, Soares MF, Schor N, Freire AO, Teixeira VP: Electroacupuncture and moxibustion decrease renal sympathetic nerve activity and retard progression of renal disease in rats. Kidney Blood Press Res 2012;35:355-364
37. Tylicki L, Lizakowski S, Rutkowski P, Renke M, Sulikowska B, Heleniak Z, Donderski R, Bednarski R, Przybylska M, Manitius J, Rutkowski B: The enhanced renin-Angiotensin-Aldosteron system pharmacological blockade- which is the best? Kidney Blood Press Res 2012;36:335-343
38. Bliss DZ, Stein TP, Schleifer CR, Settle RG: Supplementation with gum arabic fiber increases fecal nitrogen excretion and lowers serum urea nitrogen concentration in chronic renal failure patients consuming a lowprotein diet. Am J Clin Nutr 1996;63:392-398
39. Ali BH, Al Qarawi AA, Haroun EM, Mousa HM: The effect of treatment with gum Arabic on gentamicin nephrotoxicity in rats: A preliminary study. Ren Fail 2003;25:15-20
40. Ali BH, Al Husseni I, Beegam S, Al Shukaili A, Nemmar A, Schierling S, Queisser N, Schupp N: Effect of gum arabic on oxidative stress and inflammation in adenine-induced chronic renal failure in rats. PLoS One 2013;8:e55242
41. Ali BH, Al Salam S, Al H, I, Kayed RR, Al Masroori N, Al Harthi T, Al Zaabi M, Nemmar A: Effects of Gum Arabic in rats with adenine-induced chronic renal failure. Exp Biol Med (Maywood) 2010;235:373-382
42. Teichberg S, Wingertzahn MA, Moyse J, Wapnir RA: Effect of gum arabic in an oral rehydration solution on recovery from diarrhea in rats. J Pediatr Gastroenterol Nutr 1999;29:411-417
43. Schneeman BO: Fiber, inulin and oligofructose: Similarities and differences. J Nutr 1999;129:1424S-1427S
44. Nasir O, Artunc F, Wang K, Rexhepaj R, Foller M, Ebrahim A, Kempe DS, Biswas R, Bhandaru M, Walter M, Mohebbi N, Wagner CA, Saeed AM, Lang F: Downregulation of mouse intestinal Na(+)-coupled glucose transporter SGLT1 by gum arabic (Acacia Senegal). Cell Physiol Biochem 2010;25:203-210
45. Wright EM, Martin MG, Turk E: Intestinal absorption in health and disease-sugars. Best Pract Res Clin Gastroenterol 2003;17:943-956
46. Martin MG, Wang J, Solorzano-Vargas RS, Lam JT, Turk E, Wright EM: Regulation of the human Na(+)-glucose cotransporter gene, SGLT1, by HNF-1 and Sp1. Am J Physiol Gastrointest Liver Physiol 2000;278:G591-G603
47. Loflin P, Lever JE: HuR binds a cyclic nucleotide-dependent, stabilizing domain in the 3' untranslated region of Na(+)/glucose cotransporter (SGLT1) mRNA. FEBS Lett 2001;509:267-271
48. Hirsh AJ, Cheeseman CI: Cholecystokinin decreases intestinal hexose absorption by a parallel reduction in SGLT1 abundance in the brush-border membrane. J Biol Chem 1998;273:14545-14549
49. Vayro S, Silverman M: PKC regulates turnover rate of rabbit intestinal Na+-glucose transporter expressed in COS-7 cells. Am J Physiol 1999;276:C1053-C1060
50. Ferraris RP, Diamond JM: Specific regulation of intestinal nutrient transporters by their dietary substrates. Annu Rev Physiol 1989;51:125-141
51. Ishikawa Y, Eguchi T, Ishida H: Mechanism of beta-Adrenergic agonist-induced transmural transport of glucose in rat small intestine. Regulation of phosphorylation of SGLT1 controls the function. Biochim Biophys Acta 1997;1357:306-318
52. Stumpel F, Kucera T, Gardemann A, Jungermann K: Acute increase by portal insulin in intestinal glucose absorption via hepatoenteral nerves in the rat. Gastroenterology 1996;110:1863-1869
53. Cheeseman CI: Upregulation of SGLT-1 transport activity in rat jejunum induced by GLP-2 infusion in vivo. Am J Physiol 1997;273:R1965-R1971
54. Lane RH, Dvorak B, MacLennan NK, Dvorakova K, Halpern MD, Pham TD, Philipps AF: IGF alters jejunal glucose transporter expression and serum glucose levels in immature rats. Am J Physiol Regul Integr Comp Physiol 2002;283:R1450-R1460
55. Rexhepaj R, Artunc F, Metzger M, Skutella T, Lang F: PI3-kinase-dependent electrogenic intestinal transport of glucose and amino acids. Pflugers Arch 2007;453:863-870
56. Artunc F, Rexhepaj R, Volkl H, Grahammer F, Remy C, Sandulache D, Nasir O, Wagner CA, Alessi DR, Lang F: Impaired intestinal and renal glucose transport in PDK-1 hypomorphic mice. Am J Physiol Regul Integr Comp Physiol 2006;291:R1533-R1538
57. Dieter M, Palmada M, Rajamanickam J, Aydin A, Busjahn A, Boehmer C, Luft FC, Lang F: Regulation of glucose transporter SGLT1 by ubiquitin ligase Nedd4-2 and kinases SGK1, SGK3, and PKB. Obes Res 2004;12:862-870
58. Grahammer F, Henke G, Sandu C, Rexhepaj R, Hussain A, Friedrich B, Risler T, Metzger M, Just L, Skutella T, Wulff P, Kuhl D, Lang F: Intestinal function of gene-targeted mice lacking serum- And glucocorticoid-inducible kinase 1. Am J Physiol Gastrointest Liver Physiol 2006;290:G1114-G1123
59. Sandu C, Rexhepaj R, Grahammer F, McCormick JA, Henke G, Palmada M, Nammi S, Lang U, Metzger M, Just L, Skutella T, Dawson K, Wang J, Pearce D, Lang F: Decreased intestinal glucose transport in the sgk3-knockout mouse. Pflugers Arch 2005;451:437-444
60. Osswald C, Baumgarten K, Stumpel F, Gorboulev V, Akimjanova M, Knobeloch KP, Horak I, Kluge R, Joost HG, Koepsell H: Mice without the regulator gene Rsc1A1 exhibit increased Na+-D-glucose cotransport in small intestine and develop obesity. Mol Cell Biol 2005;25:78-87
61. Veyhl M, Keller T, Gorboulev V, Vernaleken A, Koepsell H: RS1 (RSC1A1) regulates the exocytotic pathway of Na+-D-glucose cotransporter SGLT1. Am J Physiol Renal Physiol 2006;291:F1213-F1223
62. Wingertzahn MA, Teichberg S, Wapnir RA: Stimulation of non-sodium-dependent water, electrolyte, and glucose transport in rat small intestine by gum arabic. Dig Dis Sci 2001;46:1105-1112
63. Koh-Banerjee P, Franz M, Sampson L, Liu S, Jacobs DR, Jr., Spiegelman D, Willett W, Rimm E: Changes in whole-grain, bran, and cereal fiber consumption in relation to 8-y weight gain among men. Am J Clin Nutr 2004;80:1237-1245
64. McKeown NM, Meigs JB, Liu S, Saltzman E, Wilson PW, Jacques PF: Carbohydrate nutrition, insulin resistance, and the prevalence of the metabolic syndrome in the Framingham Offspring Cohort. Diabetes Care 2004;27:538-546
65. Chandalia M, Garg A, Lutjohann D, von Bergmann K, Grundy SM, Brinkley LJ: Beneficial effects of high dietary fiber intake in patients with type 2 diabetes mellitus. N Engl J Med 2000;342:1392-1398
66. Delzenne NM, Cani PD: A place for dietary fibre in the management of the metabolic syndrome. Curr Opin Clin Nutr Metab Care 2005;8:636-640
67. Babiker R, Merghani TH, Elmusharaf K, Badi RM, Lang F, Saeed AM: Effects of Gum Arabic ingestion on body mass index and body fat percentage in healthy adult females: Two-Arm randomized, placebo controlled, doubleblind trial. Nutr J 2012;11:111
68. Calame W, Thomassen F, Hull S, Viebke C, Siemensma AD: Evaluation of satiety enhancement, including compensation, by blends of gum arabic. A methodological approach. Appetite 2011;57:358-364
69. Deaglio S, Aydin S, Vaisitti T, Bergui L, Malavasi F: CD38 at the junction between prognostic marker and therapeutic target. Trends Mol Med 2008;14:210-218
70. Dinarello CA: The paradox of pro-inflammatory cytokines in cancer. Cancer Metastasis Rev 2006;25:307-313
71. Katzav S: Vav: Captain Hook for signal transduction? Crit Rev Oncog 1995;6:87-97
72. Kanai Y, Endou H: Heterodimeric amino acid transporters: Molecular biology and pathological and pharmacological relevance. Curr Drug Metab 2001;2:339-354
73. Aka JA, Mazumdar M, Lin SX: Reductive 17beta-hydroxysteroid dehydrogenases in the sulfatase pathway: Critical in the cell proliferation of breast cancer. Mol Cell Endocrinol 2009;301:183-190
74. Lai JP, Thompson JR, Sandhu DS, Roberts LR: Heparin-degrading sulfatases in hepatocellular carcinoma: Roles in pathogenesis and therapy targets. Future Oncol 2008;4:803-814
75. Orlowski RZ, Kuhn DJ: Proteasome inhibitors in cancer therapy: Lessons from the first decade. Clin Cancer Res 2008;14:1649-1657
76. Sancho-Martinez I, Martin-Villalba A: Tyrosine phosphorylation and CD95: A FAScinating switch. Cell Cycle 2009;8:838-842
77. Jin T, George F, I, Sun J: Wnt and beyond Wnt: Multiple mechanisms control the transcriptional property of betacatenin. Cell Signal 2008;20:1697-1704
78. Kim YS, Milner JA: Dietary modulation of colon cancer risk. J Nutr 2007;137:2576S-2579S
79. Nasir O, Wang K, Foller M, Bhandaru M, Sandulache D, Artunc F, Ackermann TF, Ebrahim A, Palmada M, Klingel K, Saeed AM, Lang F: Downregulation of angiogenin transcript levels and inhibition of colonic carcinoma by gum arabic (Acacia senegal). Nutr Cancer 2010;62:802-810
80. Cummings JH, Bingham SA, Heaton KW, Eastwood MA: Fecal weight, colon cancer risk, and dietary intake of nonstarch polysaccharides (dietary fiber). Gastroenterology 1992;103:1783-1789
81. Fuchs CS, Giovannucci EL, Colditz GA, Hunter DJ, Stampfer MJ, Rosner B, Speizer FE, Willett WC: Dietary fiber and the risk of colorectal cancer and adenoma in women. N Engl J Med 1999;340:169-176
82. Finley JW, Burrell JB, Reeves PG: Pinto bean consumption changes SCFA profiles in fecal fermentations, bacterial populations of the lower bowel, and lipid profiles in blood of humans. J Nutr 2007;137:2391-2398
83. Ishikawa S, Asano T, Takenoshita S, Nozawa Y, Arihara K, Itoh M: Egg yolk proteins suppress azoxymethaneinduced aberrant crypt foci formation and cell proliferation in the colon of rats. Nutr Res 2009;29:64-69
84. Pool-Zobel BL: Inulin-type fructans and reduction in colon cancer risk: Review of experimental and human data. Br J Nutr 2005;93:S73-S90
85. Usami M, Kishimoto K, Ohata A, Miyoshi M, Aoyama M, Fueda Y, Kotani J: Butyrate and trichostatin A attenuate nuclear factor kappaB activation and tumor necrosis factor alpha secretion and increase prostaglandin E2 secretion in human peripheral blood mononuclear cells. Nutr Res 2008;28:321-328
86. Basson MD, Emenaker NJ, Hong F: Differential modulation of human (Caco-2) colon cancer cell line phenotype by short chain fatty acids. Proc Soc Exp Biol Med 1998;217:476-483
87. Campbell CT, Aich U, Weier CA, Wang JJ, Choi SS, Wen MM, Maisel K, Sampathkumar SG, Yarema KJ: Targeting pro-invasive oncogenes with short chain fatty acid-hexosamine analogues inhibits the mobility of metastatic MDA-MB-231 breast cancer cells. J Med Chem 2008;51:8135-8147
88. Chen JS, Faller DV, Spanjaard RA: Short-chain fatty acid inhibitors of histone deacetylases: Promising anticancer therapeutics? Curr Cancer Drug Targets 2003;3:219-236
89. Abdel-Rahman AM, el Sahrigy SA, Bakr SI: A comparative study of two angiogenic factors: Vascular endothelial growth factor and angiogenin in induced sputum from asthmatic children in acute attack. Chest 2006;129:266- 271
90. Hooper LV, Stappenbeck TS, Hong CV, Gordon JI: Angiogenins: A new class of microbicidal proteins involved in innate immunity. Nat Immunol 2003;4:269-273
91. Hoshino M, Takahashi M, Aoike N: Expression of vascular endothelial growth factor, basic fibroblast growth factor, and angiogenin immunoreactivity in asthmatic airways and its relationship to angiogenesis. J Allergy Clin Immunol 2001;107:295-301
92. Liote F, Champy R, Moenner M, Boval-Boizard B, Badet J: Elevated angiogenin levels in synovial fluid from patients with inflammatory arthritis and secretion of angiogenin by cultured synovial fibroblasts. Clin Exp Immunol 2003;132:163-168
93. Maruotti N, Cantatore FP, Crivellato E, Vacca A, Ribatti D: Angiogenesis in rheumatoid arthritis. Histol Histopathol 2006;21:557-566
94. Olson KA, Verselis SJ, Fett JW: Angiogenin is regulated in vivo as an acute phase protein. Biochem Biophys Res Commun 1998;242:480-483
95. Suzumori N, Zhao XX, Suzumori K: Elevated angiogenin levels in the peritoneal fluid of women with endometriosis correlate with the extent of the disorder. Fertil Steril 2004;82:93-96
96. Koutroubakis IE, Xidakis C, Karmiris K, Sfiridaki A, Kandidaki E, Kouroumalis EA: Serum angiogenin in inflammatory bowel disease. Dig Dis Sci 2004;49:1758-1762
97. Edelman SM, Kasper DL: Symbiotic commensal bacteria direct maturation of the host immune system. Curr Opin Gastroenterol 2008;24:720-724
98. Adler HS, Steinbrink K: Tolerogenic dendritic cells in health and disease: Friend and foe! Eur J Dermatol 2007;17:476-491
99. Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu YJ, Pulendran B, Palucka K: Immunobiology of dendritic cells. Annu Rev Immunol 2000;18:767-811
100. van Duivenvoorde LM, Han WG, Bakker AM, Louis-Plence P, Charbonnier LM, Apparailly F, van der Voort EI, Jorgensen C, Huizinga TW, Toes RE: Immunomodulatory dendritic cells inhibit Th1 responses and arthritis via different mechanisms. J Immunol 2007;179:1506-1515
101. Bhandaru M, Pasham V, Yang W, Bobbala D, Rotte A, Lang F: Effect of azathioprine on Na(+)/H(+) exchanger activity in dendritic cells. Cell Physiol Biochem 2012;29:533-542
102. E X, Cao Y, Meng H, Qi Y, Du G, Xu J, Bi Z: Dendritic cells of synovium in experimental model of osteoarthritis of rabbits. Cell Physiol Biochem 2012;30:23-32
103. Rotte A, Pasham V, Bhandaru M, Bobbala D, Zelenak C, Lang F: Rapamycin sensitive ROS formation and Na(+)/H(+) exchanger activity in dendritic cells. Cell Physiol Biochem 2012;29:543-550
104. Schmid E, Bhandaru M, Nurbaeva MK, Yang W, Szteyn K, Russo A, Leibrock C, Tyan L, Pearce D, Shumilina E, Lang F: SGK3 regulates Ca(2+) entry and migration of dendritic cells. Cell Physiol Biochem 2012;30:1423-1435
105. Szteyn K, Schmid E, Nurbaeva MK, Yang W, Munzer P, Kunzelmann K, Lang F, Shumilina E: Expression and functional significance of the Ca(2+)-Activated Cl(-) channel ANO6 in dendritic cells. Cell Physiol Biochem 2012;30:1319-1332
106. Yang W, Bhandaru M, Pasham V, Bobbala D, Zelenak C, Jilani K, Rotte A, Lang F: Effect of thymoquinone on cytosolic pH and Na+/H+ exchanger activity in mouse dendritic cells. Cell Physiol Biochem 2012;29:21-30
107. Zhao H, Li M, Wang L, Su Y, Fang H, Lin J, Mohabeer N, Li D: Angiotensin II induces TSLP via an AT1 receptor/ NF-KappaB pathway, promoting Th17 differentiation. Cell Physiol Biochem 2012;30:1383-1397
108. Tarbell KV, Yamazaki S, Steinman RM: The interactions of dendritic cells with antigen-specific, regulatory T cells that suppress autoimmunity. Semin Immunol 2006;18:93-102
109. Remondo C, Cereda V, Mostbock S, Sabzevari H, Franzusoff A, Schlom J, Tsang KY: Human dendritic cell maturation and activation by a heat-killed recombinant yeast (Saccharomyces cerevisiae) vector encoding carcinoembryonic antigen. Vaccine 2009;27:987-994
110. Chorny A, Gonzalez-Rey E, Delgado M: Regulation of dendritic cell differentiation by vasoactive intestinal peptide: Therapeutic applications on autoimmunity and transplantation. Ann N Y Acad Sci 2006;1088:187-194
111. Schuurhuis DH, Fu N, Ossendorp F, Melief CJ: Ins and outs of dendritic cells. Int Arch Allergy Immunol 2006;140:53-72
112. Gelin C, Sloma I, Charron D, Mooney N: Regulation of MHC II and CD1 antigen presentation: From ubiquity to security. J Leukoc Biol 2009;85:215-224
113. Blanco P, Palucka AK, Pascual V, Banchereau J: Dendritic cells and cytokines in human inflammatory and autoimmune diseases. Cytokine Growth Factor Rev 2008;19:41-52
114. Lehner T: Special regulatory T cell review: The resurgence of the concept of contrasuppression in immunoregulation. Immunology 2008;123:40-44
115. Li MO, Flavell RA: Contextual regulation of inflammation: A duet by transforming growth factor-beta and interleukin-10. Immunity 2008;28:468-476
116. Steinman RM, Nussenzweig MC: Avoiding horror autotoxicus: The importance of dendritic cells in peripheral T cell tolerance. Proc Natl Acad Sci U S A 2002;99:351-358
117. Xuan NT, Shumilina E, Nasir O, Bobbala D, Gotz F, Lang F: Stimulation of mouse dendritic cells by Gum Arabic. Cell Physiol Biochem 2010;25:641-648
118. Ballal A, Bobbala D, Qadri SM, Foller M, Kempe D, Nasir O, Saeed A, Lang F: Anti-malarial effect of gum arabic. Malar J 2011;10:139